Abstract:Objective To investigate the changes and clinical significance of peripheral blood T lymphocyte subsets and cytokines in influenza A (H7N9) virus infection patients.Methods Twenty-three patients with H7N9 virus infection who received treatment at the First Affiliated Hospital of Soochow University from April 2013 to April 2015 were enrolled as case group.Twenty healthy subjects in the outpatient clinic during the same period were selected as control group.The percentages of T lymphocyte subsets in the peripheral blood including CD3+CD4+ T cells, CD3+CD8+ T cells, regulatory T lymphocytes (Treg), Th17, CD3+CD8-interferon (IFN)-γ+ (Th1) cells and CD3+CD8-IL-4+ (Th2) cells were detected by flow cytometry.The changes of plasma cytokines including interleukin (IL)-8, IL-18, interferon-inducible protein (IP)-10, macrophage inflammatory protein (MIP)-1b were quantified by Bio-Plex Pro human cytokine Group Ⅰ 27-plex panel and Group Ⅱ 21-plex panel.The normality test was performed by Kolmogorov-Smirnov test.Two independent samples t test were used to compare the two groups.Results The percentages of CD3+CD4+ and CD3+CD8+ T cells before treatment in case group were significantly lower than control group ([27.90±10.19]% vs [38.75±6.78]%, t=-2.726, P=0.012;[14.82±7.72]% vs [22.79±6.12]%, t=-2.556, P=0.018), while the percentages of Th17 and Th2 before treatment in case group were significantly higher than control group ([2.64±1.40]% vs [0.29±0.21]%, t=4.668, P<0.001;[2.24±2.00]% vs [0.35±0.25]%, t=2.626, P=0.014).After treatment, 15 cases achieved improvement, among which the percentages of CD3+CD4+ T cells, CD3+CD8+ T cells and Treg after treatment were significantly higher than those before treatment ([36.54±9.20]% vs [25.86±7.22]%, t=-3.339, P=0.007;[22.70±5.68]% vs [15.08±8.80]%, t=-2.811, P=0.017;[6.08±1.70]% vs [3.26±1.64]%, t=-6.670, P<0.001), while the percentages of Th17 and Th1 cells after treatment were significantly lower than those before treatment ([2.12±1.28]% vs [2.76±1.33]%, t=2.220, P=0.048;[4.00±2.13]% vs [6.97±1.81]%, t=4.407, P=0.001).A total of 8 patients died with no significance differences of all the above mentioned immunological parameters after treatment compared with before treatment (all P>0.05).Before treatment, levels of IL-8, IL-18, IP-10 and MIP-1b of case group were significantly higher than those in control group (IL-8: [23.19±14.35] vs [12.78±6.76] ng/L, t=2.277, P=0.035;IL-18:[230.55±230.18] vs [72.80±27.91] ng/L, t=2.348, P=0.036;IP-10:[28 870.55±41 815.22] vs [1 356.13±1 093.10] ng/L, t=2.371, P=0.035;MIP-1b: [197.74±119.87] vs [118.51±41.86] ng/L, t=2.198, P=0.043).Conclusions Patients with H7N9 virus infection exhibit an imbalance of T lymphocyte subsets.It is very important to monitor the changes of T lymphocyte subsets in those patients for clinical prognosis.A storm of cytokines could exist during H7N9 virus infection, which may be the main reason for multiple organ failure.

The effect of Th17 cells on A(H1N1) influenza virus clearance

Dynamic Variations in the Peripheral Blood Lymphocyte Subgroups of Patients with 2009 Pandemic H1N1 Swine-Origin Influenza A Virus Infection

Changes in peripheral immunocytes and cytokines in patients with HIN1 influenza A virus infection

[Study on Characteristics of Cellular-Mediated Immune Responses of Novel H1N1 Influenza A Patients with Pneumonia].

The Difference of T Lymphocyte Subsets Between Mild Type and Severe Type in Patients Infected with the 2009 Pandemic Influenza A (H1N1) Virus and Its Clinical Significance

Preferential loss of Th17 cells is associated with CD4 T cell activation in patients with 2009 pandemic H1N1 swine-origin influenza A infection.

Decreased Frequencies of Th17 and Tc17 Cells in Patients Infected with Avian Influenza A (H7N9) Virus.

Vγ4 + γδT Cells Aggravate Severe H1N1 Influenza Virus Infection-Induced Acute Pulmonary Immunopathological Injury via Secreting Interleukin-17A.

Changes and Clinical Significance of White Blood Cells and T Lymphocyte Subsets in Peripheral Blood in Patients with H1N1 Influenza Virus Infection

V Gamma 4+Gamma Delta T Cells Aggravate Severe H1n1 Influenza Virus Infection-Induced Acute Pulmonary Immunopathological Injury Via Secreting Interleukin-17a

STUDY ON T LYMPHOCYTE SUBGROUPS OF PATIENTS WITH INFLUENZA A(H1N1)

Variety and Clinical Significance of T Lymphocyte Subsets and Cytokines in the Peripheral Blood of Patients with Avian Influenza H7N9 Virus Infection

The Study of T-helper Cell Subpopulation Dynamic Change and Clinical Research for Children with Influenza A (H1N1) Virus Infection

Lymphocyte Subpopulation and CD4~+CD25~+Treg Signature Analysis of Patients with Severe Influenza A(H1N1) Virus Infection

Severe Infection with Avian Influenza A Virus is Associated with Delayed Immune Recovery in Survivors

[Clinical and epidemiological characteristics of 245 cases of influenza A (H3N2)].

Clinical Analysis of Severe Influenza A/H1N1 in 53 Patients

Intensive Cytokine Induction In Pandemic H1n1 Influenza Virus Infection Accompanied By Robust Production Of Il-10 And Il-6

Clinic feature and therapy effect analysis of 25 severe and critical A H1N1 influenza cases

Early Adaptive Humoral Immune Responses And Virus Clearance In Humans Recently Infected With Pandemic 2009 H1n1 Influenza Virus

Dynamic Variations of the Peripheral Blood Immune Cell Subpopulation in Patients with Critical H7N9 Swine-Origin Influenza A Virus Infection: A Retrospective Small-Scale Study.